Association Between Migraine and Ischemic Cardio-Cerebrovascular Disease (CCVD) and Effects of Triptans and Ergotamine on the Risk of Ischemic CCVD in Patients with Migraine in the Korean NHIS-HEALS Cohort
- PMID: 37460781
- DOI: 10.1007/s40261-023-01290-7
Association Between Migraine and Ischemic Cardio-Cerebrovascular Disease (CCVD) and Effects of Triptans and Ergotamine on the Risk of Ischemic CCVD in Patients with Migraine in the Korean NHIS-HEALS Cohort
Abstract
Background and objectives: Triptans and ergotamine are commonly used to treat migraine, a risk factor for ischemic stroke. This study aimed to investigate the association between migraine and ischemic cardio-cerebrovascular disease (CCVD). Further analyses were performed to examine whether symptom-relieving treatment of migraine with triptans and ergotamine reduces ischemic CCVD in migraineurs.
Methods: Participants from the Korean NHIS-HEALS cohort database were divided into patients reporting headache without migraine (HA), migraineurs who received at least one prescription for triptans or ergotamine (TE), and migraineurs who were prescribed neither triptans nor ergotamine (NTNE). Ischemic CCVDs comprised ischemic cerebrovascular diseases and cardiovascular diseases. Using cox proportional hazards regression models, primary and secondary analysis for risk of ischemic CCVDs was compared.
Results: Among 62,272 patients diagnosed with migraine or HA, men with migraine or HA numbered 14,747 and 8935, respectively, while the numbers of women were 27,836 and 10,754, respectively. The median follow-up was 6.65 years. The overall incidence rate of CCVDs was 4728/38,590 (12.25%) in females and 3158/23,682 (13.33%) in males. Compared with the HA group, the hazard ratios (HRs) (95% CIs) of the TE and NTNE groups for ischemic CCVDs were 1.18 (1.01-1.39) and 1.39 (1.28-1.50), respectively, in males, and 1.22 (1.09-1.37) and 1.53 (1.42-1.65), respectively, in females, after full adjustment for confounding variables. Compared with the NTNE group, the HRs (95% CIs) of the TE group for ischemic CCVDs were 0.86 (0.73-0.999) in males and 0.80 (0.72-0.88) in females.
Conclusions: Migraine increased the risk of ischemic CCVDs in both sexes, and migraineurs treated with triptans and ergotamine were at lower risk of ischemic CCVDs than migraineurs who did not take those medications, especially in women.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: A retrospective study based on the NHIS-HEALS cohort.PLoS One. 2021 Nov 4;16(11):e0259212. doi: 10.1371/journal.pone.0259212. eCollection 2021. PLoS One. 2021. PMID: 34735502 Free PMC article.
-
Risk of ischemic complications related to the intensity of triptan and ergotamine use.Neurology. 2006 Oct 10;67(7):1128-34. doi: 10.1212/01.wnl.0000240128.76399.fa. Neurology. 2006. PMID: 17030745
-
Higher Pulse Pressure Is Associated With Increased Risk of Cardio-cerebrovascular Disease and All-Cause Mortality: A Korean National Cohort Study.Am J Hypertens. 2022 Jul 1;35(7):647-655. doi: 10.1093/ajh/hpac043. Am J Hypertens. 2022. PMID: 35363861
-
Practical implications of the migraine cardio- and cerebrovascular association: unmet needs of patients.Cephalalgia. 2015 Feb;35(2):140-5. doi: 10.1177/0333102414554662. Epub 2014 Oct 16. Cephalalgia. 2015. PMID: 25324501 Review.
-
Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.CNS Drugs. 2005;19(7):635-42. doi: 10.2165/00023210-200519070-00005. CNS Drugs. 2005. PMID: 15984898 Review.
References
-
- Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160. https://doi.org/10.1111/j.1468-2982.2003.00824.x .
-
- Stewart W, Wood C, Reed M, Roy J, Lipton R. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008;28(11):1170–8. https://doi.org/10.1111/j.1468-2982.2008.01666.x . - DOI - PubMed
-
- Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002;22(1):54–61. https://doi.org/10.1046/j.1468-2982.2002.00310.x . - DOI - PubMed
-
- Lambert GA, Zagami AS. The mode of action of migraine triggers: a hypothesis. Headache. 2009;49(2):253–75. https://doi.org/10.1111/j.1526-4610.2008.01230.x . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical